Author

Jeffrey Switchenko

Research Associate Professor of Biostatistics and Bioinformatics, Emory University - Cited by 3,403

Biography

Jeffrey Switchenko, PhD, MS, is an Assistant Research Professor in the Department of Biostatistics and Bioinformatics at Rollins School of Public Health. As a member of the Biostatistics Shared Resource at Winship Cancer Institute, Dr. Switchenko collaborates with investigators in the areas of lymphoma and radiation oncology.Dr. Switchenko is a member of the Cancer Prevention and Control research program at Winship.
Title
Cited by
Year
Treatment outcomes and roles of transplantation and maintenance rituximab in patients with previously untreated mantle cell lymphoma: results from large real-world cohorts
P Martin, JB Cohen, M Wang, A Kumar, B Hill, D Villa, JM Switchenko, ...Journal of Clinical Oncology 41 (3), 541, 2023202
21
2023
Antibody response to COVID-19 mRNA vaccine in patients with lung cancer after primary immunization and booster: reactivity to the SARS-CoV-2 WT virus and Omicron variant
RM Valanparambil, J Carlisle, SL Linderman, A Akthar, RL Millett, L Lai, ...Journal of Clinical Oncology 40 (33), 3808-3816, 2022202
10
2022
Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough …
Impaired SARS-CoV-2 Variant Neutralization and CD+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough …MI Azeem, AK Nooka, U Shanmugasundaram, N Cheedarla, S Potdar, ...Blood Cancer Discovery 4 (2), 106-117, 2023202
8
2023
Accuracy and safety of scout dose resin yttrium-90 microspheres for radioembolization therapy treatment planning: a prospective single-arm clinical trial
N Kokabi, LA Webster, M Elsayed, JM Switchenko, B Chen, D Brandon, ...Journal of Vascular and Interventional Radiology 33 (12), 178-187. e, 2022202
5
2022
A review of hepatic epithelioid hemangioendothelioma—Analyzing patient characteristics and treatment strategies
PS Ajay, V Tsagkalidis, A Casabianca, PR Burchard, AD Melucci, ...Journal of surgical oncology 126 (8), 142-1429, 2022202
3
2022
Surgery in combination with systemic chemotherapy is associated with improved survival in stage IV gallbladder cancer
AS Casabianca, V Tsagkalidis, PR Burchard, A Chacon, A Melucci, ...European Journal of Surgical Oncology 48 (12), 2448-2454, 2022202
3
2022
Outcomes of the same‐day discharge following mastectomy before, during and after COVID‐19 pandemic
Y Olimpiadi, AR Goldenberg, L Postlewait, T Gillespie, C Arciero, T Styblo, ...Journal of Surgical Oncology 17 (5), 761-767, 030
2
2023
Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk …
PB Allen, S Goyal, J Switchenko, E Tarabadkar, S Pouch, P Parikh, ...Leukemia & Lymphoma 64 (3), 597-604, 030
2
2023
Antibody binding and neutralization of live SARS-CoV-2 variants including BA. 4/5 following booster vaccination of patients with B-cell malignancies
Antibody binding and neutralization of live SARS-CoV- variants including BA. 4/5 following booster vaccination of patients with B-cell malignanciesA Chang, A Akhtar, L Lai, VM Orellana-Noia, SL Linderman, ...Cancer research communications (1), 1684-169, 0
2
2022
The Impact of Carbohydrate Antigen 19-9 on Survival in Patients with Clinical Stage I and II Pancreatic Cancer
AD Melucci, AC Chacon, PR Burchard, V Tsagkalidis, AS Casabianca, ...Annals of Surgical Oncology 9 (13), 8536-8547, 0
2
2022
NEO-GAP: A single-arm, phase II feasibility trial of neoadjuvant gemcitabine, cisplatin, and nab-paclitaxel for resectable, high-risk intrahepatic cholangiocarcinoma
SK Maithel, JM Keilson, HST Cao, M Rupji, A Mahipal, BS Lin, MM Javle, ...Annals of Surgical Oncology, -9, 2023202
1
2023
Environmental, social and behavioral risk factors in association with spatial clustering of childhood cancer incidence
A Hüls, S Van Cor, GM Christensen, Z Li, Y Liu, L Shi, JL Pearce, ...Spatial and spatio-temporal epidemiology 45, 00582, 2023202
1
2023
Prospective Study of Allogeneic Pediatric Transplant Associated Thrombotic Microangiopathy-Novel Prognostic Markers, Biologic Interaction and Outcomes
ML Schoettler, K French, A Harris, E Bryson, B Watkins, M Qayed, ...2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023202
1
2023
1
2023
Oncologic Outcomes After Clinically Node-Negative Salvage Laryngectomy
JH Gross, MR Patel, JM Switchenko, TG Chan, HM Baddour, A Kaka, ...JAMA Otolaryngology–Head & Neck Surgery 49 (), 24-33, 2023202
1
2023